as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
3.97%
Downside
8.73%
Upside
52 Week's Low
52 Week's High
40.48%
Downside
34.12%
Upside
Check Renovorx Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$46.9M
EPS (TTM)
-0.31
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-11.4M
Revenue (TTM)
662.0K
Profit Margin
0.00%
Return On Equity TTM
3210700.00%
Compare market cap, revenue, PE, and other key metrics of Renovorx Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $46.9M | NA | NA | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Renovorx Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Renovorx Inc investment value today
Current value as on today
₹1,16,490
Returns
₹16,490
(+16.49%)
Returns from Renovorx Inc Stock
₹11,504 (+11.5%)
Dollar Returns*
₹4,985 (+4.99%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Renovorx Inc. Average target price of $5.62
Get share price movements and forecasts by analysts on Renovorx Inc.
What analysts predicted
77.58%UPSIDE
Target Price
$5.62
Current Price
$1.26
Analyzed by
9 Analysts
Target
$5.62
Renovorx Inc target price $5.62, a slight upside of 77.58% compared to current price of $1.26. According to 9 analysts rating.
Search interest for Renovorx Inc Stock has increased by 486% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:486%Â versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, RNXT stock has moved up by 12.3%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 61.9%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 174.5%
Organisation | Renovorx Inc |
Headquarters | 2570 West El Camino Real, Mountain View, CA, United States, 94040 |
CEO | Mr. Shaun R. Bagai |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Ramtin Agah M.D. | Founder, Chairman of Board & Chief Medical Officer |
Mr. Shaun R. Bagai | CEO, Secretary & Director |
Ms. Leesa Gentry | Chief Clinical Officer |
Mr. Robert Strasser | Vice President of Operations and R&D |
Mr. Ronald B. Kocak CPA, CGMA | VP, Controller & Principal Accounting Officer |
Mr. Ryan Witt | Senior VP and Head of Corporate Strategy & Partnerships |
Renovorx Inc share price today is $1.26 as on at the close of the market. Renovorx Inc share today touched a day high of $1.37 and a low of $1.21.
Renovorx Inc share touched a 52 week high of $1.69 on and a 52 week low of $0.75 on . Renovorx Inc stock price today i.e. is closed at $1.26,which is 25.44% down from its 52 week high and 68.00% up from its 52 week low.
Renovorx Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Renovorx Inc (RNXT) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Renovorx Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Renovorx Inc share’s latest price of $1.26 as on September 16, 2025 at 1:29 am IST, you will get 7.9365 shares of Renovorx Inc. Learn more about
fractional shares .